Australia's most trusted
source of pharma news
Monday, 02 June 2025
Posted 29 May 2025 PM
In a bitter blow for Moderna the Trump administration has axed US$766 million (AU$1.1 billion) worth of government funding for the late-stage development of pre-pandemic influenza vaccines.
The company revealed funding had been withdrawn in an announcement about positive interim results for its bird flu vaccine.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.